Combined Effects of Bioactive Compounds in Lipid Profile

Clinical trial NCT01562080 · COMPLETED

Trial details

NCT number: NCT01562080
Sponsor: Rottapharm Spain
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hyperlipidemia Low-density-lipoprotein-type Elevated Triglycerides

Start date: 2012-01-01
Primary completion: 2012-06-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.